Research location

Cherbourg

France

Published trials30
Site observations32
Linked trials published30
Page1 / 1
Advertisement

Research activity in Cherbourg

France

CureCurrent currently publishes aggregate city-level research activity for this location: 30 trials and 32 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Cherbourg

30 linked trials · page 1 of 1
Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)NCT07243132 · 2025-07-02 · 1 site observation
RECRUITING
PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic MalignanciesNCT06646471 · 2024-09-26 · 1 site observation
RECRUITING
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseNCT06283966 · 2024-02-21 · 1 site observation
RECRUITING
Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological CancerNCT05241405 · 2022-09-27 · 1 site observation
RECRUITING
HYdrocortisone and VAsopressin in Post-RESuscitation SyndromeNCT04591990 · 2021-05-27 · 1 site observation
RECRUITING
PremaBiom: Metatranscriptomics of the Respiratory Microbiome to Predict the Occurrence of Bronchopulmonary Dysplasia in Preterm InfantsNCT07411261 · 2026-03-01 · 1 site observation
NOT_YET_RECRUITING
Study To Assess Effectiveness and Adverse Events of Foscarbidopa/ Foslevodopa in Adult Participants With Advanced Parkinson Disease in Real Life SettingNCT06639620 · 2024-11-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in FranceNCT05697146 · 2022-12-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)NCT05308966 · 2022-05-03 · 1 site observation
COMPLETED
Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNGNCT04934865 · 2021-10-07 · 1 site observation
COMPLETED
Impact of a Phone-based Cognitive and Behavioral Therapy on Food Addiction in Patients With Severe or Morbid ObesityNCT04626570 · 2021-01-20 · 1 site observation
COMPLETED
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)NCT05049044 · 2020-12-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of the Clinical/Biological Characteristics, Efficacy and Safety of Patients With Malignant Pleural Mesothelioma, Treated by ImmunotherapyNCT04775446 · 2020-11-26 · 1 site observation
COMPLETED
A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast CancerNCT04354233 · 2020-06-24 · 1 site observation
COMPLETED
Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCFNCT04344327 · 2020-04-10 · 1 site observation
COMPLETED
Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma BreastNCT03878342 · 2019-05-10 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung CancerNCT03721120 · 2019-04-10 · 1 site observation
COMPLETED
Impact of Reducing Antihypertensive Treatment on Mortality in Frail Subjects With Low Systolic Blood Pressure (SBP).NCT03453268 · 2018-10-02 · 1 site observation
COMPLETED
Fingolimod -Response According to Coping - EvaluationNCT01420055 · 2011-08-01 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.NCT01197508 · 2010-09-01 · 1 site observation
COMPLETED
Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian CancerNCT01333748 · 2010-04-01 · 1 site observation
COMPLETED
Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive PatientsNCT01042392 · 2009-11-01 · 1 site observation
COMPLETED
Therapeutic Education by Telemedicine in Chronic Heart FailureNCT00878202 · 2009-03-01 · 1 site observation
TERMINATED
Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive DeclineNCT00506415 · 2007-06-01 · 1 site observation
COMPLETED
Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma ActivitiesNCT00242814 · 2005-11-03 · 3 site observations
COMPLETED
A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and PainNCT00191919 · 2005-05-01 · 1 site observation
COMPLETED
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionNCT00095394 · 2004-09-01 · 1 site observation
COMPLETED
Switching to Duloxetine From Other AntidepressantsNCT00191932 · 2004-08-01 · 1 site observation
COMPLETED
Post-marketing Observational Study in Subjects With Rheumatoid ArthritisNCT00234884 · 2003-09-01 · 1 site observation
COMPLETED
Long-Term Safety Of DVS-233 SR In Patients With Major Depressive DisorderNCT01309542 · 2003-08-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.